XML 24 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 4 Months Ended 6 Months Ended 10 Months Ended
Jun. 30, 2021
Jun. 30, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net loss $ (1,744,522) $ (1,042,697) $ 1,245,158
Adjustments to reconcile net loss to net cash used in operating activities:      
Unrealized gain from securities held in Trust Account 9,495 (21,508)
Realized gain from securities held in Trust Account     (21,508)
Change in fair value of warrant liability 1,462,306 (1,432,423) (2,204,598)
Interest earned on securities held in trust account (17) (147,108)  
Initial fair value of forward purchase option reported as operating expense 781,070  
Change in fair value of warrant and forward purchase option derivative liabilities 1,462,306 (1,417,551)  
Offering costs allocated to warrants 261,838   261,838
Changes in operating assets and liabilities:      
Prepaid insurance (350,000) 87,500 (262,500)
Deferred operating cost (201,405)  
Prepaid expenses (22,501) (7,499)
Income tax payable 13,526  
Franchise tax payable (68,767) 168,767
Accrued expense 360,795 1,767,234 271,792
Net cash used in operating activities (105) (250,699) (548,550)
Cash flows from investing activities:      
Investment of cash in Trust Account (117,300,000) (1,150,000) (117,300,000)
Cash transferred from Trust Account 168,617  
Net cash used in investing activities (117,300,000) (981,383) (117,300,000)
Cash flows from financing activities:      
Proceeds from issuance of Class B common stock to sponsor 25,000 25,000
Proceeds from sale of Units, net of underwriting discount paid 113,275,000 113,275,000
Payment of related party promissory note     (92,737)
Proceeds from sale of Private units 5,281,750 5,281,750
Proceeds from related party promissory note 1,150,000 92,737
Payment of offering costs (342,840) (478,677)
Net cash provided by financing activities 118,238,910 1,150,000 118,103,073
Net change in cash 938,805 (82,082) 254,523
Cash at beginning of period 254,523
Cash at end of period 938,805 172,441 254,523
Supplemental disclosure of non-cash financing activities:      
Accrued deferred offering costs 176,405  
Deferred underwriting fee payable     4,025,000
Initial classification of warrant liabilities 5,031,474 5,031,474
Offering costs charged to additional paid-in capital included in accrued expense 78,100 $ 35,000
Offering costs charged to additional paid in capital paid by promissory note-related party $ 92,737